Prof. Chun-Jiu Zhong
Principal Investigator
Research Directions
Clinical diagnosis, pathogeneses, prevention and treatment of neurodegenerative disorders, especially Alzheimer’s disease and Parkinson’s disease
Contact Information
Address：Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China
Tel: 86-21-54237920 Email: zhongcj@163.com; zhong.chunjiu@zs-hospital.sh.cn
Dr. Chunjiu Zhong received his B.S. degree in Clinical Medicine from Anhui Medical University in 1986 and M.S. degree in Neurology from (former) Shanghai Medical University in 1992. He obtained his Ph.D. degree in Neurology in 2007 from Fudan University. Since 1992, Dr. Zhong has been working at Zhongshan Hospital, Shanghai Medical University (presently Fudan University) as a clinical practicer and researcher in Neurology. In 2009, he joined the National Laboratory of Medical Neurobiology and in 2010, he joined the Institutes for Brain Science as a principal investigator. His research has been focused on Clinical diagnosis, pathogeneses, prevention and treatment of neurodegenerative disorders, especially Alzheimer’s disease and Parkinson’s disease. More than 40 research papers published in academic journals at home and abroad such as Brain, Journal of Neurochemistry, Neurobiology of Disease, European Journal of Neurology(with editorial comment), American Journal of Neuroradiology, etc.
Enrollment Major
Neurology
Research Direction
Clinical diagnosis, pathogeneses, prevention and treatment of neurodegenerative disorders, especially Alzheimer’s disease and Parkinson’s disease
Selected Publications
Pan X, Fei G, Lu J, Jin L, Pan S, Chen Z, Wang C, Sang S, Liu H, Hu W, Zhang H, Wang H, Wang Z, Tan Q, Qin Y, Zhang Q, Xie X, Ji Y, Cui D, Gu X, Xu J, Yu Y, Zhong C*(2016).Measurement of Blood Thiamine Metabolites for Alzheimer's Disease Diagnosis. EbioMedicine, 3:155-62.
Zhao L, Gong N, Liu M, Pan X, Sang S, Sun X, Yu Z, Fang Q, Zhao N, Fei G, Jin L, Zhong C*, Xu T(2014).Beneficial synergistic effects of microdose lithium with pyrroloquinoline quinone in an Alzheimer's disease mouse model. Neurobiol Aging ,35(12):2736-45.
Chen Z, Zhong C*(2013).Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol ,108:21-43.
Jin L, Wang J, Zhao L, Jin H, Fei G, Zhang Y, Zeng M, Zhong C*(2011).Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain, 134(Pt 1):50-8.
Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, Sun X, Zhao L, Yu M, Xu Z, Dong W, Qin Y, Fei G, Zhong C*, Xu TL(2010).Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice. Brain,133(Pt 5):1342-51.
